SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-002193
Filing Date
2008-02-27
Accepted
2008-02-27 16:31:44
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y50398e10vk.txt 10-K 378817
2 EX-10.11: LETTER AGREEMENT y50398exv10w11.txt EX-10.11 3134
3 EX-10.21: REVISED SCHEDULE OF PARTIES TO EMPLOYMENT y50398exv10w21.txt EX-10.21 1447
4 EX-21: SUBSIDIARIES OF THE REGISTRANT y50398exv21.txt EX-21 776
5 EX-23.1: CONSENT OF BDO SEIDMAN. LLP y50398exv23w1.txt EX-23.1 905
6 EX-23.2: CONSENT OF PRICEWATERHOUSECOOPERS LLP y50398exv23w2.txt EX-23.2 1103
7 EX-24: POWERS OF ATTORNEY y50398exv24.txt EX-24 3526
8 EX-31.1: CERTIFICATION y50398exv31w1.txt EX-31.1 4528
9 EX-31.2: CERTIFICATION y50398exv31w2.txt EX-31.2 4449
10 EX-32.1: CERTIFICATION y50398exv32w1.txt EX-32.1 1532
11 EX-32.2: CERTIFICATION y50398exv32w2.txt EX-32.2 1461
  Complete submission text file 0000950123-08-002193.txt   403203
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10638 | Film No.: 08646915
SIC: 2834 Pharmaceutical Preparations